Lung Cancer,SCLC (Small Cell Lung Cancer) Efficacy of Senaparib + Low-Dose Temozolomide in Relapsed ES-SCLC Dec 29, 2023
Lung Cancer,SCLC (Small Cell Lung Cancer) Tarlatamab in SCLC: Early Results From DeLLphi-301 Trial Dec 14, 2023
Lung Cancer,SCLC (Small Cell Lung Cancer) Correlation Between Clinical and HRQoL Benefits in ALK+ NSCLC: ALTA-1L Study Nov 28, 2023
Lung Cancer,SCLC (Small Cell Lung Cancer) Cobolimab + Dostarlimab Shows Efficacy in Advanced NSCLC post Anti-PD(L)-1 Therapy Nov 28, 2023
Lung Cancer,SCLC (Small Cell Lung Cancer) ATZ-TBP Shows Favorable Benefit-risk Profile In Extensive-Stage SCLC Nov 17, 2023
Lung Cancer,SCLC (Small Cell Lung Cancer) Cabozantinib Shows Improved Outcomes Vs. Placebo For Advanced NET Nov 16, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer),SCLC (Small Cell Lung Cancer) Multisite SBRT + Ipilimumab + Nivolumab Is Well-Tolerated In First Line Metastatic NSCLC Nov 14, 2023
Lung Cancer,SCLC (Small Cell Lung Cancer) Carboplatin, Etoposide, Bevacizumab, And Atezolizumab Regimen Well Tolerated In ES-SCLC Patients Nov 09, 2023
